Articles Vol. 65 No. 2 08/03/2024

34. EVALUATION OF THE SAFETY OF STEMSUP AEROSOL THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTION PULMONARY DISEASE

Bui Duc Thanh1,2, Nguyen Hai Cong1,2, Nguyen Minh The1,2
1 Military Hospital 175
2 Bệnh viện quân y 175
Corresponding author: Nguyen_med@gmail.com
DOI: 10.52163/yhc.v65i2.953
14 Views
12 Downloads
Keywords
Chronic obstruction pulmonary disease, stemsup, safety.
Abstract

Objective: To describe the clinical and paraclinical characteristics and initially evaluate the safety of Stemsup aerosol therapy in patients with chronic obstructive pulmonary disease.

Materials and Methods: This is an interventional, open-label, single-group study on 30 patients with COPD groups C and D treated at the Tuberculosis and Lung Disease Department of Military Hospital 175 from 8/2021 - 12/2023.

Results: 100% of patients were male, with an average age of 67.5 ± 6.9 years old. The average mMRC score was 2.23 ± 0.57. 6MWT is 326.7 ± 88.2 m. The average CAT score was 18.1 ± 4.9 points. The average BODE score is 4.33 ± 1.62, of which BODE III accounts for the highest percentage (40%),and the lowest is BODE IV accounting for 10%. The average values of lung ventilation indicators in the studied patients all decreased compared to LLN, in which FEV1(%LLN) decreased significantly (45.1 ± 14.9%LLN). Side effects only occurred in 1 case of increased difficulty breathing, accounting for 3.3%. 13.3% of patients had a mild and transient increase in CRP after 1 month of Stemsup aerosol therapy. There were no cases of serious complications after using Stemsup.

Conclusion: Stemsup aerosol therapy in COPD patients was well tolerated without significant serious side effects. This is a promising method for the treatment of COPD patients.

References
[1]
Lopez AD, Shibuya K, Rao C et al., Chronic Google Scholar
[2]
obstructive pulmonary disease: current burden Google Scholar
[3]
and future projections. The European respiratory Google Scholar
[4]
journal 2006, 27(2):397-412. Google Scholar
[5]
Mathers CD, Loncar D, Projections of global Google Scholar
[6]
mortality and burden of disease from 2002 to Google Scholar
[7]
PLoS medicine 2006, 3(11):e442. Google Scholar
[8]
Miniño AM, Murphy SL, Xu J et al., Deaths: Google Scholar
[9]
final data for 2008, United States. National vital Google Scholar
[10]
statistics reports: from the Centers for Disease Google Scholar
[11]
Control and Prevention, National Center for Google Scholar
[12]
Health Statistics, National Vital Statistics System Google Scholar
[13]
, 59(10):1-126. Google Scholar
[14]
Wu M, Han Z-B, Liu JF et al., Serum-free Google Scholar
[15]
media and the immunoregulatory properties of Google Scholar
[16]
mesenchymal stem cells in vivo and in vitro. Google Scholar
[17]
Cellular Physiology and Biochemistry 2014, Google Scholar
[18]
(3):569-580. Google Scholar
[19]
Tamama K, Kerpedjieva SS, Acceleration of Google Scholar
[20]
Wound Healing by Multiple Growth Factors and Google Scholar
[21]
Cytokines Secreted from Multipotential Stromal Google Scholar
[22]
Cells/Mesenchymal Stem Cells. Advances in Google Scholar
[23]
wound care 2012, 1(4):177-182. Google Scholar
[24]
Gupta N, Malhotra N, Ish P, GOLD 2021 Google Scholar
[25]
guidelines for COPD—what’s new and why. Google Scholar
[26]
Advances in respiratory medicine 2021, Google Scholar
[27]
(3):344-346. Google Scholar
[28]
Lê Thị Bích Phượng, Nghiên cứu hiệu quả của tế Google Scholar
[29]
bào gốc trung mô dây rốn trẻ sơ sinh trong điều Google Scholar
[30]
trị bệnh phổi tắc nghẽn mạn tính; Luận án tiến sĩ, Google Scholar
[31]
Học viện quân y; 2023. Google Scholar
[32]
Weiss DJ, Casaburi R, Flannery R et al., Google Scholar
[33]
A placebo-controlled, randomized trial of Google Scholar
[34]
mesenchymal stem cells in COPD; Chest 2013, Google Scholar
[35]
(6):1590-1598. Google Scholar
[36]
Ribeiro-Paes JT, Bilaqui A, Greco OT et al., Google Scholar
[37]
Unicentric study of cell therapy in chronic Google Scholar
[38]
obstructive pulmonary disease/pulmonary Google Scholar
[39]
emphysema; International journal of chronic Google Scholar
[40]
obstructive pulmonary disease 2011:63-71. Google Scholar